↓ Skip to main content

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Published in
Journal for Immunotherapy of Cancer, February 2019
DOI 10.1186/s40425-019-0523-2
Pubmed ID
Authors

Mirjam Fässler, Stefan Diem, Joanna Mangana, Omar Hasan Ali, Fiamma Berner, David Bomze, Sandra Ring, Rebekka Niederer, Cristina del Carmen Gil Cruz, Christian Ivan Pérez Shibayama, Michal Krolik, Marco Siano, Markus Joerger, Mike Recher, Lorenz Risch, Sabine Güsewell, Martin Risch, Daniel E. Speiser, Burkhard Ludewig, Mitchell P. Levesque, Reinhard Dummer, Lukas Flatz

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 92 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 11%
Student > Master 10 11%
Researcher 8 9%
Student > Bachelor 7 8%
Student > Doctoral Student 7 8%
Other 10 11%
Unknown 40 43%
Readers by discipline Count As %
Medicine and Dentistry 13 14%
Biochemistry, Genetics and Molecular Biology 13 14%
Immunology and Microbiology 7 8%
Agricultural and Biological Sciences 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 5 5%
Unknown 44 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2020.
All research outputs
#8,478,408
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,025
of 3,424 outputs
Outputs of similar age
#150,563
of 366,923 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#72
of 93 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.